1. A PROSPECTIVE UKRAINIAN MULTICENTRE COHORT STUDY OF PET VALUE PROGNOSTIC ROLE IN PRIMARY PATIENTS WITH HODGKIN LYMPHOMA (HL): HIGHLIGHTING CLINICAL RELEVANCE. (17th June 2021) Authors: Novosad, O.; Pastushenko, I.; Gorbach, O.; Kozlov, V.; Mykhalska, L.; Kindrakevych, O.; Novikov, M.; Karnabeda, O.; Oliinichenko, O.; Kmetyuk, Y.; Karpova, O.; Ashykhmin, A.; Rudiuk, T.; Kriachok, I. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB1846: ALTERATIONS IN PRIMARY HEMOSTASIS AS ADDITIONAL RISK FACTORS OF BLEEDING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): UPDATED PROSPECTIVE ANALYSIS. (23rd June 2022) Authors: Stupakova, Z.; Iryna, D.; Zoya, M.; Anna, S.; Karnabeda, O.; Melnyk, U.; Novosad, O. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA. (23rd June 2022) Authors: Novosad, O.; Pastushenko, I.; Kadnikova, T.; Tytorenko, I.; Martynchyk, A.; Gorbach, O.; Ashyhmin, A.; Kmetyuk, Y.; Karpova, O.; Mykhalska, L.; Kindrakevych, O.; Novikov, M.; Oliinichenko, O.; Kriachok, I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1936 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PB2114: TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA FROM HIGH-RISK GROUP. (23rd June 2022) Authors: Filonenko, K.; Kriachok, I.; Martynchyk, A.; Titorenko, I.; Stepanishyna, Y.; Aleksyk, O.; Ukianchenko, K.; Pastushenko, I.; Kushchevyy, Y.; Novosad, O.; Karnabeda, O.; Diagil, I.; Kozlov, V. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1985 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PB2283: COVID-19 (SARS-COV-2 INFECTION) IN LYMPHOMA PATIENTS. (23rd June 2022) Authors: Tytorenko, I.; Kryachоk, I.; Alexik, O.; Kadnikova, T.; Martynchik, A.; Novosad, O.; Pastyshenko, Y.; Stepanishina, Y.; Shokun, N.; Filonenko, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SUBTYPES OF MALIGNANT LYMPHOMAS IN UKRAINE, ACCORDING TO 2016 WHO CLASSIFICATION. PRELIMINARY REPORT OF THE UKRAINIAN LYMPHOMA REGISTRY. (17th June 2021) Authors: Skrypets, T.; Stepanishyna, Y.; Galli, G. R.; Manni, M.; Hubareva, A.; Tytorenko, I.; Martynchyk, A.; Aleksik, O.; Shudrak, N.; Pastushenko, Y.; Novosad, O.; Filonenko, K.; Kadnikova, T.; Kushchevyi, Y.; Federico, M.; Kriachok, I. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗